Daniel Lynch - Insider Trading & Ownership

Entity
Individual
Summary
The estimated net worth of Daniel Lynch is at least $14.7M dollars as of May 17, 2024. Daniel Lynch is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $14.6M. Daniel Lynch is the Director of 2seventy bio, Inc. and owns shares of 2seventy bio, Inc. (TSVT) stock worth about $145K. Daniel Lynch is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. (BLUE) stock worth about $11.4K.
All Insider Reports
All Insider Reports

Ownership of Daniel Lynch

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SWTX SpringWorks Therapeutics, Inc. Director $14.6M May 16, 2024
TSVT 2seventy bio, Inc. Director $145K Jun 13, 2023
BLUE bluebird bio, Inc. Director $11.4K Nov 11, 2021
XLO Xilio Therapeutics, Inc. Director, 10%+ Owner Oct 21, 2021

Insider Transactions Reported by Daniel Lynch:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.